185 related articles for article (PubMed ID: 3922616)
1. Netilmicin in the treatment of Pseudomonas bacteremia.
Lorber RR; Linzmayer MI
Clin Ther; 1985; 7(3):338-46. PubMed ID: 3922616
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.
Buckwold FJ; Ronald AR; Lank B; Thompson L; Fox L; Harding GK
Can Med Assoc J; 1979 Jan; 120(2):161-7. PubMed ID: 761144
[TBL] [Abstract][Full Text] [Related]
3. Netilmicin in urinary tract infections.
Svare J; Johnsen NJ; Vesterhauge S; Lund F; Thomsen J; Vejlsgaard R
Scand J Infect Dis Suppl; 1980; Suppl 23():132-4. PubMed ID: 6937957
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study on netilmicin in the treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa].
Murahashi I; Honda M; Maeda S; Takasaki E
Jpn J Antibiot; 1982 Aug; 35(8):1919-24. PubMed ID: 6818388
[TBL] [Abstract][Full Text] [Related]
5. Netilmicin therapy of patients with septicaemia and other severe infections.
Brandenhoff P; Stafanger G; Gammelgaard PA; Rasmussen F; Jensen SH; Bretlau P; Thomsen VF
Scand J Infect Dis Suppl; 1980; Suppl 23():181-5. PubMed ID: 6937965
[TBL] [Abstract][Full Text] [Related]
6. Netilmicin in the treatment of severe or complicated urinary tract infections.
Peddie BA; Bailey RR; Blake E; Summerfield MJ
N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
[TBL] [Abstract][Full Text] [Related]
7. Netilmicin in the treatment of infections in patients with cancer.
Yap BS; Bodney GP
Arch Intern Med; 1979 Nov; 139(11):1259-62. PubMed ID: 389189
[TBL] [Abstract][Full Text] [Related]
8. Netilmicin therapy of serious Gram-negative bacillary infections.
Edelstein PH; Meyer RD
J Antimicrob Chemother; 1978 Nov; 4(6):495-502. PubMed ID: 711647
[No Abstract] [Full Text] [Related]
9. [Effectiveness of netilmicin in the treatment of urinary tract infections].
Borówka A; Mészáros J; Krzeski T; Wolnik Z; Jeljaszewicz J
Pol Tyg Lek; 1983 Oct; 38(41):1285-7. PubMed ID: 6424104
[No Abstract] [Full Text] [Related]
10. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
Jansen W; Schwarz A
Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
[TBL] [Abstract][Full Text] [Related]
13. Netilmicin therapy of patients with leukaemia or malignant lymphoma.
Geisler C; Hansen MM; Mortensen N; Traun-Pedersen P
Scand J Infect Dis Suppl; 1980; Suppl 23():176-80. PubMed ID: 6937964
[TBL] [Abstract][Full Text] [Related]
14. [Netilmicin in refractory urinary tract infections. Good therapeutic effect in spite of long dosage intervals].
Brunner FP; Wenk M; Mauracher E; Thiel G; Follath F
Schweiz Med Wochenschr; 1982 Jun; 112(26):934-41. PubMed ID: 7112061
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
[TBL] [Abstract][Full Text] [Related]
16. Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates.
Peitersen B; Hørlyk H; Nielsen M; Prag J; Korner B; Heilesen AM; Friis-Møller A
Scand J Infect Dis Suppl; 1980; Suppl 23():151-4. PubMed ID: 6937961
[TBL] [Abstract][Full Text] [Related]
17. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
Henriksson P; Svenningsen NW; Juhlin I; Haeger K
Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
[TBL] [Abstract][Full Text] [Related]
19. Netilmicin: chemical development and overview of clinical research.
Herting RL; Lane AZ; Lorber RR; Wright JJ
Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
[TBL] [Abstract][Full Text] [Related]
20. [Bolus injection, short infusion or intravenous drip of aminoglycoside antibiotics? In vivo study with netilmicin and Pseudomonas aeruginosa].
Brugger HP; Gerber AU; Feller-Segessenmann C
Schweiz Med Wochenschr; 1983 Dec; 113(49):1858-60. PubMed ID: 6427922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
